St Jude to invest up to $200 million in arrhythmia firm Epicor
This article was originally published in Clinica
Executive Summary
St Jude Medical (St Paul, Minnesota) has invested $15m in a minority interest in Epicor Medical, of Sunnyvale California. It says it has also reserved the right to pay a further $185m to buy Epicor outright in 2004, if the latter's high intensity focused ultrasound (HIFU) minimally invasive ablation system to treat atrial fibrillation (AF) meets certain clinical and regulatory milestones.